These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35814996)

  • 21. The Prevalence of Dry Eye Disease and Related Factors Among Adult Patients Attending Primary Healthcare Centers in Riyadh, Saudi Arabia.
    AlMarshedi MM; Alshammari SA
    Cureus; 2022 Nov; 14(11):e31400. PubMed ID: 36514647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
    Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
    BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose.
    Cohen S; Martin A; Sall K
    Clin Ophthalmol; 2014; 8():157-64. PubMed ID: 24403819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship Between Screen Time and Dry Eye Symptoms During the COVID-19 Pandemic in the Pediatric Population of the Western Region of Saudi Arabia.
    Alnahdi W; Hadrawi M; Danish E; Alghamdi A; Taher N; Alfaraidi AT; Alageel N
    Cureus; 2022 Nov; 14(11):e31015. PubMed ID: 36475117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
    Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
    Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.
    Burillon C; Chiambaretta F; Pisella PJ
    Clin Ophthalmol; 2018; 12():2629-2636. PubMed ID: 30587909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
    Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
    Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wang L; Cao K; Wei Z; Baudouin C; Labbé A; Liang Q
    Ophthalmic Res; 2020; 63(5):443-451. PubMed ID: 31884498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical corticosteroids for dry eye.
    Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders.
    Cagini C; Torroni G; Mariniello M; Di Lascio G; Martone G; Balestrazzi A
    Int Ophthalmol; 2021 Sep; 41(9):3065-3071. PubMed ID: 33956256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial.
    Leonardi A; Van Setten G; Amrane M; Ismail D; Garrigue JS; Figueiredo FC; Baudouin C
    Eur J Ophthalmol; 2016 Jun; 26(4):287-96. PubMed ID: 27055414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized multicenter clinical evaluation of sequential application of 0.3% and 0.15% hyaluronic acid for treatment of dry eye.
    Jun JH; Bang SP; Park HS; Yoon D; Ahn JY; Kim SJ; Kim HK
    Jpn J Ophthalmol; 2022 Jan; 66(1):58-67. PubMed ID: 34843023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease.
    Mun C; Gulati S; Tibrewal S; Chen YF; An S; Surenkhuu B; Raju I; Buwick M; Ahn A; Kwon JE; Atassi N; Pradeep A; Rondelli D; Jain S
    Transl Vis Sci Technol; 2019 May; 8(3):10. PubMed ID: 31110911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
    Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
    Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
    Baudouin C; de la Maza MS; Amrane M; Garrigue JS; Ismail D; Figueiredo FC; Leonardi A
    Eur J Ophthalmol; 2017 Nov; 27(6):678-685. PubMed ID: 28708219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.